Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bachem Holding AGBCHMF 91 EV-to-OCF is 19.53 as of Jul. 31, 2026, which is 59% below its 10-year median of 47.69. GuruFocus rates BCHMF with a GF Score™ of 91/100 and a GF Value™ of $102.00 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 1,410 Biotechnology companies, Bachem Holding AG ranks worse than 88.87% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Bachem Holding AG's Enterprise Value is $6,613.8 Mil.
Bachem Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $338.6 Mil. Therefore, Bachem Holding AG's EV-to-OCF for today is 19.53.
The historical rank and industry rank for Bachem Holding AG's EV-to-OCF or its related term are showing as below:
BCHMF'
s EV-to-OCF Range Over the Past 10 Years
Min: 15.23 Med: 47.69 Max: 101.76
Current: 20.36
During the past 13 years, the highest EV-to-OCF of Bachem Holding AG was 101.76. The lowest was 15.23. And the median was 47.69.
BCHMF's EV-to-OCF is ranked worse than 88.87% of 1410
companies
in the Biotechnology industry
Industry Median: -3.2
vs BCHMF: 20.36
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bachem Holding AG (OTCPK:BCHMF) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bachem Holding AG's PE Ratio (TTM) for today is calculated as:
Bachem Holding AG's share price for today is $87.34.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bachem Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $2.468.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Bachem Holding AG EV-to-OCF Related Terms
Bachem Holding AG EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Bachem Holding AG's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Bachem Holding AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bachem Holding AG EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bachem Holding AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Bachem Holding AG's EV-to-OCF falls into.
Bachem Holding AG's current Enterprise Value is $6,613.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bachem Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $338.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bachem Holding AG (BCHMF) has a EV-to-OCF of 19.53 as of Jul. 31, 2026. This is 59% below median its historical median of 47.69. Over the past decade, Bachem Holding AG's EV-to-OCF has ranged from 15.23 to 101.76. According to the industry distribution chart, Bachem Holding AG ranks #1253 out of 1410 companies in the Biotechnology industry, placing it in the top 88.9%.
Is Bachem Holding AG's EV-to-OCF too high?
Bachem Holding AG's current EV-to-OCF of 19.53 is 59% below median its 10-year median of 47.69. Over the past 10 years, this metric has ranged from a low of 15.23 to a high of 101.76. Based on the distribution chart, Bachem Holding AG ranks #1253 out of 1410 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bachem Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's EV-to-OCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #1253 out of 1410 companies for EV-to-OCF. This places Bachem Holding AG in the lower half of its industry. Historically, Bachem Holding AG's own EV-to-OCF has ranged from 15.23 to 101.76 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Bachem Holding AG's current EV-to-OCF is 19.53, which is 59% below median its own 10-year median of 47.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $102.00, compared to a current price of $87.34 — trading 14.4% below its estimated fair value. The current EV-to-OCF is 19.53, which is 59% below median its 10-year median of 47.69. Bachem Holding AG's overall GF Score™ is 91/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current EV-to-OCF is 19.53 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bachem Holding AG (BCHMF) Overvalued in 2026?
Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued.
The current stock price of $87.34 is trading 14.4% below its estimated GF Value™ of $102.00.
GuruFocus considers Bachem Holding AG to be Modestly Undervalued.
Key valuation signals for BCHMF:
EV-to-OCF: 19.53 (59% below median its 10-year median of 47.69)
GF Value™: $102.00 vs. price of $87.34 (14.4% below fair value)
No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
91GF Score
Get the complete analysis for BCHMF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCHMF has been successfully added to your 
